- Home
- INDO vs EDSA Comparison
INDO vs EDSA Comparison
Compare INDO & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INDO | EDSA |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | Indonesia | Canada |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.2M | 51.5M |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | INDO | EDSA |
|---|---|---|
| Price | $2.84 | $4.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 197.4K | 36.8K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.44 | $0.72 |
| 52 Week High | $8.50 | $20.32 |
Technical Indicators
Market Signals| Indicator | INDO | EDSA |
|---|---|---|
| Relative Strength Index (RSI) | 42.64 | 35.06 |
| Support Level | $2.72 | $3.84 |
| Resistance Level | $3.03 | $5.10 |
| Average True Range (ATR) | 0.11 | 0.27 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 4.93 | 14.32 |
Price Performance
Historical ComparisonAbout INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.